2021 Project: Johns Hopkins University

SARS-CoV-2 genome: viral evolution as a factor of sustained community transmission and prolonged infection

What to know

Johns Hopkins University provided real-time data describing the evolution of the SARS-CoV-2 virus in communities and individuals. Awarded in 2021, this study provided data to help identify whether changes in the SARS-CoV-2 genome meant a variant could spread more easily or make people sicker. Researchers used novel methods to study how the virus evolves.

Decorative image with words "2021" and "SARS-CoV-2"

Findings on SARS-CoV-2 surveillance and investigations

This project:

  • Implemented infection prevention policies to reduce the risk of SARS-CoV-2 transmission between patients and healthcare workers.1
  • Generated genomes that were used for SARS-CoV-2 genomic surveillance and contact tracing and that led to identification of the first cluster of the South African variant in the State of Maryland.2
  • Found that SARS-CoV-2 viruses carrying the spike protein mutation E484K were disproportionately prevalent among persons infected after full vaccination against COVID-19 compared with infected persons who were not fully vaccinated. 3
  • Identified clusters of transmission within Johns Hopkins Hospital (two studies)45

Findings on SARS-CoV-2 variant characteristics

This project found:

  • Compared with the Delta variant, the Omicron variant was more likely to cause breakthrough infections in vaccinated individuals, yet hospital admissions were less likely. 6
  • Certain viral variants or mutations were associated with breakthrough infection after vaccination. 7
  • In both vaccinated and unvaccinated persons, the Delta variant was associated with higher viral loads than the Alpha variant. 8
  • Prolonged infections, prolonged viral shedding, and viral reinfections were revealed by genomic surveillance. 9
  • SARS-CoV-2 genomic diversity was reported over time in the National Capital Region as well as differences in clinical severity among lineages. 10
  • The Delta variant was associated with more severe disease in hospitalized patients. 11
  1. . Infect Control Hosp Epidemiol, 2022.
  2. MMWR Morb Mortal Wkly Rep. 2021 Apr 30;70(17):627-631. doi: 10.15585/mmwr.mm7017a5
  3. Clin Infect Dis. 2022 Jun 10;74(11):2053-2056. doi: 10.1093/cid/ciab762.
  4. Infect Control Hosp Epidemiol. 2022 Dec;43(12):1983-1985. doi: 10.1017/ice.2021.469. Epub 2021 Nov 8.
  5. Open Forum Infect Dis. 2021 Mar 12;8(4):ofab121. doi: 10.1093/ofid/ofab121. eCollection 2021 Apr.
  6. . eBioMedicine, 2022.
  7. . J Clin Virol, 2022
  8. . Clin Infect Dis, 2021.
  9. . Front Cell Infect Microbiol, 2022.
  10. . Clin Infect Dis, 2022.
  11. . medRxiv, 2022.